The Animal Enterprise Terrorism Act was overwhelmingly embraced by the pharmaceutical industry. The National Association for Biomedical Research (NABR) lauded the passage of the bill stating, „Today, the AETA provides greater protection for the biomedical research community and their families against intimidation and harassment, and addresses for the first time in federal law, campaigns of secondary and tertiary targeting that cause economic damage to research enterprises.“[